Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,154,400
+$30,815,900 QoQ
Shares Held
880,000
+151.4% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#31
of 329 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. PCVX ranks #24 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in PCVX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,154,400 | 880,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,338,500 | 350,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $79,591,500 | 1,725,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,994,660 | 333,000 | Shares | Sole | 2025-11-14 | |
| 2024-06-30 | $6,424,994 | 85,088 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,812,361 | 85,088 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,425,526 | 150,088 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,733,846 | 132,088 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,000,794 | 60,088 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $16,303,800 | 435,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $38,120,250 | 795,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,400,000 | 100,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,151,104 | 52,900 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||